Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals had revenue of $171.17M in the quarter ending March 31, 2026, with 0.38% growth. This brings the company's revenue in the last twelve months to $720.53M, down -1.39% year-over-year. In the year 2025, Amphastar Pharmaceuticals had annual revenue of $719.89M, down -1.65%.

• Revenue (ttm): $720.53M
• Revenue Growth: -1.39%
• P/S Ratio: 1.13
• Revenue / Employee: $364,641
• Employees: 1,976
• Market Cap: 811.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	719.89M	-12.08M	-1.65%
Dec 31, 2024	731.97M	87.57M	13.59%
Dec 31, 2023	644.40M	145.41M	29.14%
Dec 31, 2022	498.99M	61.22M	13.98%
Dec 31, 2021	437.77M	87.92M	25.13%
Dec 31, 2020	349.85M	27.49M	8.53%
Dec 31, 2019	322.36M	27.69M	9.40%
Dec 31, 2018	294.67M	54.49M	22.69%
Dec 31, 2017	240.18M	-14.99M	-5.87%
Dec 31, 2016	255.17M	3.65M	1.45%
Dec 31, 2015	251.52M	41.06M	19.51%
Dec 31, 2014	210.46M	-19.22M	-8.37%
Dec 31, 2013	229.68M	25.36M	12.41%
Dec 31, 2012	204.32M	85.97M	72.63%
Dec 31, 2011	118.36M	-12.38M	-9.47%
Dec 31, 2010	130.74M	46.46M	55.13%
Dec 31, 2005	84.28M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error